|
Real-time Estimate
Cboe BZX
11:24:39 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 15.96 USD | +2.01% |
|
+5.57% | -30.83% |
| 10-19 | Ultragenyx Pharmaceutical Enters Settlement With Navinta Over Dojolvi | MT |
| 10-14 | Ultragenyx Pharmaceutical to Sell Priority Review Voucher for $203 Million | DJ |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.01% | +5.57% | +10.41% | -40.83% | -30.83% | -54.94% | -53.90% | -80.24% | -74.80% | 1.54B | |
| +0.22% | +3.01% | +7.84% | +6.69% | +18.89% | +54.60% | +124.90% | +414.27% | +1,564.49% | 1,135B | |
| +0.79% | +4.91% | -2.10% | +0.11% | +28.65% | +39.91% | +78.69% | +60.63% | +132.41% | 635B | |
| +0.25% | +1.20% | +7.43% | +11.35% | +25.20% | +25.45% | +97.02% | +161.28% | +368.81% | 505B | |
| +1.29% | +4.16% | +11.40% | +9.94% | +20.63% | +48.06% | +66.87% | +10.60% | +74.79% | 378B | |
| -2.45% | -1.29% | -4.65% | +8.42% | +34.69% | +61.10% | +34.32% | +72.36% | +132.91% | 358B | |
| -0.81% | +2.21% | +4.56% | -1.23% | +15.82% | +23.05% | +49.18% | +63.02% | +78.29% | 295B | |
| -0.09% | +3.35% | +2.59% | -0.56% | -7.06% | +2.15% | +23.33% | +42.35% | +168.29% | 266B | |
| +0.47% | +3.91% | +5.60% | +17.35% | +34.90% | +51.65% | +63.71% | +111.59% | +177.72% | 237B | |
| +1.44% | +3.24% | +3.83% | +21.08% | +28.76% | +31.18% | +101.32% | +133.33% | +109.65% | 193B | |
| +0.20% | +1.60% | +3.31% | -20.18% | -19.88% | -23.35% | -61.48% | -23.98% | +89.53% | 172B | |
| -0.62% | +1.53% | +4.07% | +21.16% | +20.04% | +20.67% | -4.08% | -31.38% | -7.75% | 171B | |
| -2.20% | +1.73% | -3.23% | +6.61% | +12.63% | +21.53% | +41.34% | +177.42% | +548.76% | 133B | |
| -0.29% | +4.05% | -4.18% | -2.16% | +13.48% | +41.07% | +15.56% | +5.10% | +24.18% | 126B | |
| -0.22% | -1.12% | +16.68% | +17.54% | +21.80% | +23.13% | +121.22% | +380.42% | +530.08% | 117B | |
| +0.82% | +2.91% | +2.63% | -2.65% | +4.63% | +16.40% | +29.48% | +6.48% | -6.11% | 102B | |
| +0.47% | +4.90% | +3.46% | -4.24% | -9.95% | -15.48% | -25.85% | -13.03% | +9.37% | 99.44B | |
| -0.14% | +2.78% | +6.85% | +20.47% | +4.13% | +37.32% | +1.48% | +35.73% | +121.37% | 80.39B | |
| -0.38% | -12.67% | +0.44% | +256.17% | +571.89% | +643.21% | +160.78% | -42.69% | - | 79.89B | |
| +1.50% | +8.56% | +4.25% | -7.00% | -16.33% | -0.55% | +56.47% | +62.44% | +479.58% | 71.3B | |
| Average | +0.09% | +1.82% | +4.06% | +15.90% | +38.60% | +52.31% | +46.02% | +77.29% | +237.98% | 257.82B | |
| Weighted average by Cap. | +0.04% | +1.60% | +4.24% | +9.99% | +27.04% | +44.71% | +70.09% | +148.26% | +482.49% |
- Stock Market
- Stocks
- RARE Stock
- Sector Ultragenyx Pharmaceutical Inc.
Select your edition
All financial news and data tailored to specific country editions
